Gregory Grunberg's most recent trade in 89bio Inc was a trade of 27,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 89bio Inc | Gregory Grunberg | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 27,400 | 27,400 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Gregory Grunberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | Gregory Grunberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Gregory Grunberg | Director | Sale of securities on an exchange or to another person at price $ 27.60 per share. | 21 Apr 2021 | 850 | 0 (0%) | 0% | 27.6 | 23,460 | Common Stock |
| 89bio Inc | Gregory Grunberg | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Gregory Grunberg | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 16 Nov 2020 | 850,000 | 1,750,877 (12%) | 6% | 0 | Common Stock | |
| 89bio Inc | Gregory Grunberg | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 16 Nov 2020 | 850 | 850 (0%) | 0% | 0 | Common Stock |